SU988278A1 - Device for investigating kidneys evacuation function - Google Patents
Device for investigating kidneys evacuation function Download PDFInfo
- Publication number
- SU988278A1 SU988278A1 SU813303686A SU3303686A SU988278A1 SU 988278 A1 SU988278 A1 SU 988278A1 SU 813303686 A SU813303686 A SU 813303686A SU 3303686 A SU3303686 A SU 3303686A SU 988278 A1 SU988278 A1 SU 988278A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- patient
- kidneys
- drug
- minutes
- bladder
- Prior art date
Links
Landscapes
- Nuclear Medicine (AREA)
Description
(54) СПОСОБ ИССЛЕДОВАНИЯ ОЧИСТИТЕЛЬНОЙ ФУНКЦИИ ПОЧЕК(54) METHOD FOR INVESTIGATING KIDNEY FUNCTIONAL FUNCTION
1one
Изобретение относитс к медицине, а именно к радиоизотопной диагностике.The invention relates to medicine, namely to radioisotope diagnostics.
Известен способ исследовани очистительной функции почек путем регистрации излучени всего тела больного и внутривенного введени радиофармацевтического препарата 1. Однако известный способ не обеспечивает высокой точности исследовани и возможна больша лучева нагрузка на больного .There is a known method for studying kidney cleansing function by registering radiation of the entire body of a patient and intravenous administration of radiopharmaceutical drug 1. However, the known method does not provide high accuracy of research and a greater radiation load on the patient is possible.
Целью изобретени вл етс повышение точности диагностики и снижение лучевой нагрузки.. .The aim of the invention is to improve the accuracy of diagnosis and reduce radiation exposure.
Цель достигаетс тем, что согласно способу исследовани очистительной функции почек путем регистрации излучени всего тела больного и внутривенного введени радиофармацевтического препарата в, течение 15-20 мин определ ют временное/распределение препарата в каждой из почек с ис пользованием двух каналов регистрации двух параллельно фокусирующих коллиматоров , после чего в течение 5-6 мин устанавливают распределение препарата во всем теле больного, почках и мочевом пузыре в положении пациента на спине и животе до и после опорожнени мочевого пу-зыр и раздельно определ ют количество препарата в теле пациента и в иочевывод щей системе.The goal is achieved by the method of studying kidney cleansing function by registering the radiation of the patient’s whole body and intravenous radiopharmaceutical for 15–20 minutes, determining the time / distribution of the drug in each of the kidneys using two recording channels of two parallel focusing collimators, after that, within 5-6 minutes, the distribution of the drug is established throughout the patient’s body, kidneys and bladder in the patient’s position on the back and abdomen before and after emptying Ochev PU-zyr separately and the amount of drug in the patient is determined and in iochevyvod boiling system.
Способ осуш.ествл ют следующим образом .The method is dried as follows.
Больного укладывают на диагностический стол в горизонтальном положении на спине, строго по осевой линии скеннара. Один ограничитель возвратно-поступательного движени детектора скеннара устанавливают уа уровне гребешков подвздошной кости пациента, второй- выше на 25-30 см дл взрослых и на 20 см дл детей, определ зоны скеннирювани почек. После внутри15 венного введени радиофармацевтического препарата (РФП) провод т запись ренограмм дл каждой почки в течение 15- 20 мин. По окончании исследовани больной .остаетс лежать на спине, ограничители устанавливают в положение дл скен20 нировани всего тела пациента, коллиматорные насадки мен ютс на дивергентные, дл регистрации излучени от всего тела пациента в поперечном направлении, запись производ т в суммарном режиме. Затем больThe patient is placed on the diagnostic table in a horizontal position on the back, strictly along the centerline of the scannar. One limiter of the reciprocating movement of the scanner detector sets the ya level of the patient’s iliac bone scallops, the second one is 25-30 cm higher for adults and 20 cm higher for children, and defines kidney scanning zones. After intravenous administration of a radiopharmaceutical (RFP), renograms are recorded for each kidney for 15-20 minutes. At the end of the study, the patient lies on his back, the limiters are set to scan for the entire body of the patient, the collimator caps change to divergent, to record radiation from the patient’s entire body in the transverse direction, the recording is made in cumulative mode. Then pain
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU813303686A SU988278A1 (en) | 1981-05-11 | 1981-05-11 | Device for investigating kidneys evacuation function |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU813303686A SU988278A1 (en) | 1981-05-11 | 1981-05-11 | Device for investigating kidneys evacuation function |
Publications (1)
Publication Number | Publication Date |
---|---|
SU988278A1 true SU988278A1 (en) | 1983-01-15 |
Family
ID=20963966
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU813303686A SU988278A1 (en) | 1981-05-11 | 1981-05-11 | Device for investigating kidneys evacuation function |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU988278A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8693741B2 (en) | 2008-10-09 | 2014-04-08 | Siemens Medical Solutions Usa, Inc. | Methods and apparatus for analyzing medical imaging data |
-
1981
- 1981-05-11 SU SU813303686A patent/SU988278A1/en active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8693741B2 (en) | 2008-10-09 | 2014-04-08 | Siemens Medical Solutions Usa, Inc. | Methods and apparatus for analyzing medical imaging data |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Enlander et al. | Renal cortical imaging in 35 patients: superior quality with 99mTc-DMSA | |
Strauss et al. | Thallium-201: non-invasive determination of the regional distribution of cardiac output | |
Rutlen et al. | Radionuclide assessment of peripheral intravascular capacity: a technique to measure intravascular volume changes in the capacitance circulation in man. | |
Kuhl et al. | Local cerebral blood volume determined by three-dimensional reconstruction of radionuclide scan data. | |
Lim et al. | Kinetics of trace element chromium (III) in the human body | |
Ruotsalainen et al. | Estimated radiation dose to the newborn in FDG-PET studies | |
Groshar et al. | Renal function and technetium-99m-dimercaptosuccinic acid uptake in single kidneys: the value of in vivo SPECT quantitation | |
Siegel et al. | Thallium-201 peripheral perfusion scans: feasibility of single-dose, single-day, rest and stress study | |
SU988278A1 (en) | Device for investigating kidneys evacuation function | |
Yankelevitz et al. | MR appearance of radiation hepatitis | |
Callahan et al. | Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG: comparison with indium-111-DTPA-IgG | |
Matsumori et al. | Persistent uptake of indium-111-antimyosin monoclonal antibody in patients with myocardial infarction | |
Gilday et al. | Accuracy of brain scanning in pediatric craniocerebral neoplasms | |
Williams et al. | Concentration of radioactive chlormerodrin in the fluid of chronic subdural hematoma | |
Wong et al. | Right ventricular ejection fraction measured by first-pass intravenous krypton-81m: reproducibility and comparison with technetium-99m | |
Yasky et al. | An assessment of the “radioactive renogram” using O-iodohippurate sodium (Hippuran) labelled with radioactive iodine | |
OLDENDORF et al. | Clinical measurement of brain uptake of radioisotope | |
Ryan et al. | KADIATION ABSORBED DOSE ESTIMATE FOR RDBIDIOM-82 DETEIMZNED FROM IN VIVO MEASUREMENTS IN HUMAN SUBJECTS | |
Ferrer et al. | Dosimetric impact of correcting count losses due to deadtime in clinical radioimmunotherapy trials involving iodine-131 scintigraphy | |
SU906517A1 (en) | Method of determining portal hypertension | |
Rosen et al. | Predicting splenic abnormality in Hodgkin disease using volume response to epinephrine administration. | |
Kuikka et al. | Initial human studies with single-photon emission tomography using iodine-123 labelled 3-(5-cyclopropyl-1, 2, 4-oxadiazo-3-yl)-7-iodo-5, 6-dihydro-5-methyl-6-oxo-4H-imidazo [1, 5-a][1, 4]-benzodiazepine (NNC 13-8241) | |
SU1673054A1 (en) | Method for determining clearance function of excretory organs | |
SU906519A1 (en) | Method of radionuclide diagnosis of kidney function | |
SU1168191A1 (en) | Method of determining diuresis |